Latest Articles
Endometriosis Clinical Trial Analysis: Key Insights into Rich - openPR.com
Endometriosis Clinical Trial Analysis: Key Insights into Rich openPR.com
Published: June 25, 2025, 1:31 p.m.
Randomized Clinical Trial Tests Effects of CBD on Behavior in Boys with Severe Autism - Cannabis Science and Technology
Randomized Clinical Trial Tests Effects of CBD on Behavior in Boys with Severe Autism Cannabis Science and Technology
Published: June 24, 2025, 10:22 p.m.
Childhood traumatic events associated with endometriosis risk - Clinical Trials Arena
Childhood traumatic events associated with endometriosis risk Clinical Trials Arena
Published: June 17, 2025, 9:27 a.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Clinical Trials Arena
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Clinical Trials Arena
Published: June 10, 2025, 9:06 a.m.
Endometriosis linked with increased risk of autoimmune disease - Clinical Trials Arena
Endometriosis linked with increased risk of autoimmune disease Clinical Trials Arena
Published: May 23, 2025, 3:24 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - BioSpace
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids BioSpace
Published: May 7, 2025, 1:28 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - The Manila Times
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids The Manila Times
Published: May 7, 2025, 12:24 p.m.
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - PR Newswire
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids PR Newswire
Published: May 7, 2025, noon
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - 스페셜타임스
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids 스페셜타임스
Published: May 7, 2025, noon
Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results - Medical Xpress
Molecular profiling can safely reduce radiation for women with endometrial cancer: Clinical trial results Medical Xpress
Published: May 4, 2025, 9 p.m.
Link copied to clipboard!